- US-listed companies
- HALOZYME THERAPEUTICS, INC.
- Financials
- Common stock and paid-in capital
HALOZYME THERAPEUTICS, INC. (HALO)
Market cap
$7.9B
P/E ratio
| Period End | Common stock and paid-in capital (Million USD) | YoY (%) |
|---|---|---|
| Dec 31, 2024 | 0 | -3.15% |
| Dec 31, 2023 | 0 | -5.93% |
| Dec 31, 2022 | 0 | -2.17% |
| Dec 31, 2021 | 0 | +2.22% |
| Dec 31, 2020 | 0 | -1.46% |
| Dec 31, 2019 | 0 | -5.52% |
| Dec 31, 2018 | 0 | +1.40% |
| Dec 31, 2017 | 0 | +10.00% |
| Dec 31, 2016 | 0 | +1.56% |
| Dec 31, 2015 | 0 | +1.59% |
| Dec 31, 2014 | 0 | +9.57% |
| Dec 31, 2013 | 0 | +2.03% |
| Dec 31, 2012 | 0 | +8.38% |
| Dec 31, 2011 | 0 |